Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and Probiotics in Newly Diagnosed Type 2 Diabetes
NCT02861261Phase 3Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Aug 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of berberine in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Hemoglobin A1c at 13 weeks. Status: unknown.
02
Drugs
berberine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02861261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02861261.